DeFRA Questionnaire as an Anamnestic Form
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02003716|
Recruitment Status : Completed
First Posted : December 6, 2013
Last Update Posted : November 13, 2014
|Condition or disease|
There is an increasing recognition that the management of osteoporosis requires the characterization of fracture risk to be based on absolute risk rather than single measures such as bone mineral density (BMD). However, the threshold for pharmacological intervention for osteoporosis remains controversial.
The aim of the present project is to perform a large scale study to identify subjects at risk of osteoporosis by administering the DeFRA questionnaire in a population never screened or treated before for osteoporosis.
DeFRA questionnaire will be administered before and after DEXA scanning, to further validate the questionnaire and to highlight the predictive value of this protocol as a tool to screen the general population.
|Study Type :||Observational|
|Actual Enrollment :||767 participants|
|Observational Model:||Ecologic or Community|
|Official Title:||Use of the DeFRA Questionnaire as a "Primary Anamnestic Form" Through a Large Scale Screening of the Population|
|Study Start Date :||September 2013|
|Actual Primary Completion Date :||March 2014|
|Actual Study Completion Date :||March 2014|
- percent risk of a fracture [ Time Frame: day 1 ]The DeFRA questionnaire is administered within the same day with or without the DeXA measurement, to evaluate statistically significant differences in the percent risk of a fracture
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02003716
|Valmontone, Roma, Italy|
|Principal Investigator:||Vincenzo Dell'Anna, Dr.||Valmontone Hospital|